Nick Robbins-Cherry Email & Phone Number
@epsilogen.com
3 phones found area 123 and 919
LinkedIn matched
Who is Nick Robbins-Cherry? Overview
A concise factual answer block for searchers comparing this professional profile.
Nick Robbins-Cherry is listed as Biotech CFO at Epsilogen Ltd, based in Reading, England, United Kingdom. AeroLeads shows a work email signal at epsilogen.com, phone signal with area code 123, 919, and a matched LinkedIn profile for Nick Robbins-Cherry.
Nick Robbins-Cherry previously worked as Chief Financial Officer at Epsilogen Ltd and Chief Financial Officer at Ixaka. Nick Robbins-Cherry holds Mba from Henley Business School.
Email format at Epsilogen Ltd
This section adds company-level context without repeating Nick Robbins-Cherry's masked contact details.
AeroLeads found 1 current-domain work email signal for Nick Robbins-Cherry. Compare company email patterns before reaching out.
About Nick Robbins-Cherry
Big 4 trained Chartered Accountant and MBA with extensive fund-raising, public markets and PE experience gained through finance and commercial roles in international pharmaceuticals, technology services, software and telecoms businesses. I am currently Chief Financial Officer of a UK headquartered private cell and gene therapy business, Ixaka Limited, with manufacturing and R&D operations in Spain and France.Strategic and commercial leader with the skills and experience to work effectively across all levels of an organisation. In a former role as CFO of Midatech Pharma PLC I steered that business through IPOs on AIM and NASDAQ and subsequent fundraising rounds. Successful negotiator with excellent communication skills and an extensive track record in M&A.
Listed skills include Finance, Mergers And Acquisitions, Accounting, Business Strategy, and 10 others.
Nick Robbins-Cherry's current company
Company context helps verify the profile and gives searchers a useful next step.
Nick Robbins-Cherry work experience
A career timeline built from the work history available for this profile.
Chief Financial Officer
Innovative cell and gene therapy company developing multi-cell and gene delivery technologies for the treatment of a broad range of serious diseases. GMP certified manufacturing and R&D operation in Seville, Spain, and a state-of-the-art R&D facility in Paris, France.
Chief Financial Officer
Strategic sale to Octopus Investments (Fern Fibre), unlocking a £200m funding commitment to enable an ambitious enterprise fibre deployment programme.
Chief Financial Officer
Fundraising activities in the US and UK were adversely impacted by the COVID pandemic and following a review of options to refinance the business, Senzer was sold to a strategic partner.
Chief Financial Officer
- Successful IPO on AIM in December 2014 following a rapid, 3-month process raising £32m. - In parallel with the AIM float completed the acquisition of Q Chip Limited which brought a complimentary platform technology and suite of pipeline products. - Completed a NASDAQ dual-listing in December 2015 which facilitated the acquisition of DARA BioSciences Inc., a US listed, cancer supportive care business with a portfolio of 5 marketed products. This acquisition provides the commercial infrastructure needed for Midatech’s pipeline products when they reach market. - Acquired the anti-emetic product Zuplenz 2 weeks after closing the DARA deal. - Successful integration of acquired business, swiftly moving to a single corporate identity and company culture along with unified finance and IT systems. - Secondary fundraises completed in October 2016 raising double the target in a difficult market and October 2017. - Implemented SAP Business One business management system and new IT infrastructure across all Group locations. - Starting with nothing, devised and implemented new internal control and corporate governance frameworks suitable for a public company.
Finance And Commercial Director
Finance Director
M&A Manager
Finance Director
Healthcare technology business, spun-out from J&J.
Financial Controller And Special Projects Manager
Business Recovery And Insolvency Manager
Nick Robbins-Cherry education
Mba
Bsc, Pharmacology
Frequently asked questions about Nick Robbins-Cherry
Quick answers generated from the profile data available on this page.
What company does Nick Robbins-Cherry work for?
Nick Robbins-Cherry works for Epsilogen Ltd.
What is Nick Robbins-Cherry's role at Epsilogen Ltd?
Nick Robbins-Cherry is listed as Biotech CFO at Epsilogen Ltd.
What is Nick Robbins-Cherry's email address?
AeroLeads has found 1 work email signal at @epsilogen.com for Nick Robbins-Cherry at Epsilogen Ltd.
What is Nick Robbins-Cherry's phone number?
AeroLeads has found 3 phone signal(s) with area code 123, 919 for Nick Robbins-Cherry at Epsilogen Ltd.
Where is Nick Robbins-Cherry based?
Nick Robbins-Cherry is based in Reading, England, United Kingdom while working with Epsilogen Ltd.
What companies has Nick Robbins-Cherry worked for?
Nick Robbins-Cherry has worked for Epsilogen Ltd, Ixaka, Vorboss, Senzer Limited, and Midatech Pharma Plc.
How can I contact Nick Robbins-Cherry?
You can use AeroLeads to view verified contact signals for Nick Robbins-Cherry at Epsilogen Ltd, including work email, phone, and LinkedIn data when available.
What schools did Nick Robbins-Cherry attend?
Nick Robbins-Cherry holds Mba from Henley Business School.
What skills is Nick Robbins-Cherry known for?
Nick Robbins-Cherry is listed with skills including Finance, Mergers And Acquisitions, Accounting, Business Strategy, Change Management, Business Analysis, Business Transformation, and Forecasting.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial